Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
startups
tc
boston blog main
boston top stories
clinical trials
deals
fda
indiana blog main
investing
life sciences
national blog main
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
seattle blog main
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
arrowmark partners
artificial intelligence
avrobio
beta bionics
bigfoot biomedical
bioinformatics
biology
boston
boston university
boulder/denver blog main
boulder/denver top stories
brexanolone
camp4 therapeutics
cancer
cancer immunotherapy
congenital hyperinsulinism
crispr therapeutics
crispr-cas9
denali therapeutics
detroit blog main
What
key
5
×
million
startup
called
closed
company
drug
focus
global
human
medicine
round
unlocking
ahead
ambien
american
annual
approach
approaches
asco
attendees
attention
beta
bionics
biopharmaceutical
biotech
blood
body
breaking
camp’s
cancer
cash
celgene
cells
celularity
chicago
city
clinical
closes
combinations
Language
unset
Current search:
key
×
biotech
×
@techcrunch.com
2 years ago
GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor
@techcrunch.com
2 years ago
Federated Genomic data startup Lifebit raises $60M round led by Tiger Global
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@techcrunch.com
6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas
